TD Cowen cuts target for UnitedHealth stock from USD 430.00 to USD 402.00

Published on 10/09/2026 at 15:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings per share hit USD 6.38 for the June quarter. UnitedHealth stock costs EUR 334.40 on October 9, 2026, up 1.67 percent on the prior close.

Key points in brief

TD Cowen cut its UnitedHealth price target from USD 430.00 to USD 402.00 while keeping a Hold rating on October 9, 2026.
UnitedHealth's adjusted earnings per share reached USD 6.38 in the second quarter of 2026, while the medical care ratio improved to 86.70 percent.
The Lang & Schwarz quote was EUR 334.40 on October 9, 2026 at 3:13 p.m. CEST, up 1.67 percent versus the EUR 328.90 prior close.
UnitedHealth is scheduled to report third-quarter 2026 results before the market opens on October 13, 2026.

Architekturaufnahme eines symmetrischen Unternehmensgebäudes mit Herbstbäumen und Spiegelteich — UnitedHealth Group US91324P1021 repräsentiert durch generischen Corporate Campus mit Herbstbäumen in Minnesota, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) saw TD Cowen cut its price target from USD 430.00 to USD 402.00 while keeping a Hold rating on October 9, 2026, according to Investing.com. The change puts the upcoming third-quarter report at the center of the debate, while UnitedHealth stock was trading at EUR 334.40 at Lang & Schwarz on October 9, 2026 at 3:13 p.m. CEST, up 1.67 percent.

Three milestones shape the setup

On July 16, 2026, UnitedHealth reported second-quarter revenue of USD 112.03 billion and adjusted earnings per share of USD 6.38, according to Investing.com. On August 12, 2026, the board authorized a quarterly dividend of USD 2.32 per share, according to Business Wire. On October 9, 2026, TD Cowen lowered its target from USD 430.00 to USD 402.00, the latest dated event.

What does the target cut mean?

TD Cowen's October 9 note kept the Hold rating and said third-quarter 2026 consensus earnings per share of USD 4.12 and a medical loss ratio of 89.90 percent appeared achievable, according to Investing.com. The same report cited a projected decline in four-star or higher contracts to 68.00 percent from 80.00 percent and estimated a USD 1.5 billion revenue headwind in 2028.

The operating picture still contains a measurable counterweight. UnitedHealth's medical care ratio improved to 86.70 percent in the second quarter of 2026 from 89.40 percent a year earlier, while adjusted earnings per share rose from USD 4.08 to USD 6.38, according to Yahoo Finance. That comparison explains why the target reduction is more focused on future Medicare Advantage economics than on the latest quarter's reported result.

Dates investors have next

UnitedHealth will release third-quarter 2026 results before the market opens on October 13, 2026, and its investor call is scheduled for 8:00 a.m. ET, according to UnitedHealth Group. The company said the webcast replay will remain available through October 27, 2026.

Stock value and trading context

UnitedHealth's market capitalization was USD 336.9 billion on October 8, 2026, while its 52-week range was USD 255.97 to USD 461.62. The Lang & Schwarz price of EUR 334.40 stood above the EUR 328.90 prior close on October 9, 2026, producing a plus 1.67 percent daily change in the same euro quotation.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.